Gilead Sciences (GILD)

EBITDA Growth

-375.90%

Quarterly · Period ending:

GILD logo

GILD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-375.90%
GILD Quarterly EBITDA YoY % (100.00% → -375.90%)
High-resolution chart · PNG

GILD ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences EBITDA Growth — Quarterly
Period endingEBITDA Growth
-1,087.2599%
-1,334.9807%
-128.806%
22.0897%
72.5935%
88.5103%
65.8163%
-80%
51.267%
-17.913%
-17.3653%
9.0909%
-2,628.5714%
-3.6036%
-45.2174%
-326.9841%
95.0355%
9.0164%
171.5909%
-78.481%
-37.0787%
-25.7143%
-9.7222%
-7.2289%
4.4776%
-14.7541%
-35.8491%
-27.6923%
-63.4146%
-84.8485%
-120.8333%
9.7222%
-920%
-1,750%
-1,300%
-46.9388%
400%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.